Significant knowledge gaps exist regarding the precise TH-mediated molecular and biochemical mechanisms that control brain and cardiac physiopathology and the optimal strategies for the management of thyroid dysfunction in patients with and without pre-existing cardiovascular disease. The gene discussed is TH; the disease is cardiovascular disorder.